No sign of stopping: The rise of cell and gene therapy
Drug Discovery World
MAY 22, 2023
Ryan Leahy , a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector. But are these price tags a barrier to access? Simply, yes, as we saw when the European Commission rejected the price point for bluebird bio’s Zynteglo.
52 
Let's personalize your content